第一作者:
Lauré M,Fijen
第一单位:
From the Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam (L.M.F., D.M.C.); the Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, La Jolla (M.A.R.), Ionis Pharmaceuticals, Carlsbad (L.B., V.J.A., K.B.N., A.R., B.F.B., C.N., A.R.M., E.S.), and the Division of Allergy, Immunology, and Rheumatology, University of California, Los Angeles, Los Angeles (R.T.) - all in California; the Department of Internal Medicine, Division of Immunology-Allergy Section and the Bernstein Clinical Research Center, University of Cincinnati College of Medicine, Cincinnati (J.A.B.); the Midwest Immunology Clinic, Plymouth, MN (J.R.); the Department of Medicine and Pediatrics, Penn State Health Allergy, Asthma, and Immunology, Hershey, PA (T.C.); Asthma and Allergy Research Associates, Dallas (W.R.L.); and Medical Research of Arizona, Scottsdale (M.E.M.).
作者:
主题词
成年人(Adult);女(雌)性(Female);人类(Humans);男(雄)性(Male);血管水肿, 遗传性(Angioedemas, Hereditary);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);寡核苷酸类, 反义(Oligonucleotides, Antisense);前激肽释放酶(Prekallikrein);生活质量(Quality of Life);RNA, 信使(RNA, Messenger)
DOI
10.1056/NEJMoa2109329
PMID
35294812
发布时间
2024-02-29
- 浏览0

The New England journal of medicine
1026-1033页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文